Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Alcohol Misuse, Gut Microbial Dysbiosis and PrEP Care Continuum: Application and Efficacy of SBIRT Intervention (SEAL)

NCT06005298 is registered in ClinicalTrials.gov with Shirish S Barve as lead sponsor.

NCT NCT06005298
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06005298 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Alcohol Misuse, Gut Microbial Dysbiosis and PrEP Care Continuum: Application and Efficacy of SBIRT Intervention (SEAL)
Lead sponsor
Shirish S Barve
Phase
Not applicable
Overall status
Recruiting
Start date
August 1, 2023
Completion date
October 24, 2027
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alcohol use disorder, dysbiosis, hiv infections, risk behavior, health